Product Image
Invitrogen™

pcDNA™3.2/GW/D-TOPO™ Expression Kit

Die pcDNA™ Vektoren wurden für hohe, konstitutive Expression in verschiedenen Säugetierzelllinien konzipiert. Der pcDNA3.2/GW/D-TOPO-Vektor bietet die folgenden Hauptmerkmale:•Czytomegalievirus (CMV)-Promotor fürWeitere Informationen
Have Questions?
KatalognummerMenge
K24402020 Reaktionen
Katalognummer K244020
Preis (EUR)
1.180,80
Exklusiv online
1.440,00
Ersparnis 259,20 (18%)
Each
Menge:
20 Reaktionen
Preis (EUR)
1.180,80
Exklusiv online
1.440,00
Ersparnis 259,20 (18%)
Each
Die pcDNA™ Vektoren wurden für hohe, konstitutive Expression in verschiedenen Säugetierzelllinien konzipiert. Der pcDNA3.2/GW/D-TOPO-Vektor bietet die folgenden Hauptmerkmale:

•Czytomegalievirus (CMV)-Promotor für High-Level-Expression
•Adaptiert für direktionale TOPO™-Klonierung, ermöglicht Ihnen die Verwendung von Proofreading-Polymerasen und das Klonen Ihrer PCR-Produkte in einer bestimmten Ausrichtung
•Neomycin-Resistenzgen für stabile Selektion
•C-terminal V5-Tag für einfachen Nachweis
•Ampicillin-Resistenzgen und pUC-Ursprung für die Auswahl und Wartung in E. coli

TOPO™-Klonierung
Die Verwendung von Restriktionsenzymen zum Klonen Ihres Gens in einen Expressionsvektor zwingt Sie oft dazu, die endgültige Sequenz Ihres Einsatzes zu gefährden (Abbildung 1A), besonders wenn es keine nützlichen Restriktionsstellen in der Nähe Ihrer Gen-Codierungssequenz gibt. Dies kann zu einem suboptimalen Abstand von Expressionselementen oder zur Integration nicht-nativer Aminosäurereste führen. Dies kann die Expressionswerte verringern und/oder die Produktion von nicht-funktionellen Proteinen verursachen.

Die TOPO™ Klonierung ist nicht nur eine effektivere Methode zum Klonen, sondern verhindert auch diese potenziellen Expressionsprobleme. TOPO™ Expressionsvektoren ermöglichen das exakte Einfügen der benötigten DNA-Sequenzen durch einfache PCR mit den entsprechend konzipierten Primern. Ihr PCR-Produkt wird mit einer hohen Effizienz innerhalb von nur fünf Minuten in einen Topoisomerase I-aktivierten Expressionsvektor geklont. Der resultierende rekombinante Expressionsvektor enthält Ihre genaue DNA-Sequenz ohne nicht-kodierende Bereiche (Abb. 1B).

Viele unserer leistungsstarken Expressionsvektoren sind für das einstufige TOPO™ Klonieren und die Expression von PCR-Produkten geeignet. Zusätzlich sind mehrere Expressionsvektoren für die direktionale TOPO™ Klonierung geeignet, wodurch die Verwendung von Proofreading-Polymerasen und die Klonierung von PCR-Produkten in einer spezifischer Ausrichtung ermöglicht wird.
Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.
Specifications
Konstitutives oder induktives SystemKonstitutiv
LiefertypTransfektion
Zur Verwendung mit (Anwendung)Konstitutive Expression
ProdukttypTOPO Expressionskit
Menge20 Reaktionen
Selektionsmittel (eukaryotisch)Geneticin™ (G-418)
VektorpcDNA
KlonierungsmethodeTOPO, Gateway, Directional TOPO
ProduktlinieGateway, TOPO, pcDNA
PromoterCMV
ProteinmarkierungV5-Epitop-Tag
Unit SizeEach
Inhalt und Lagerung
Lagerung im Ultra-Tiefkühlgerät (-68 bis -85 °C).

Häufig gestellte Fragen (FAQ)

Your Gateway-adapted TOPO vectors are supplied with a control template and control primers. Can I obtain the sequence of the control template?

The sequence of the control template is proprietary.

I performed stable selection but my antibiotic-resistant clones do not express my gene of interest. What could have gone wrong?

Here are possible causes and solutions:

Detection method may not be appropriate or sensitive enough:
- We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot.
- Insufficient number of clones screened: Screen at least 20 clones.
- Inappropriate antibiotic concentration used for stable selection: Make sure the antibiotic kill curve was performed correctly. Since the potency of a given antibiotic depends upon cell type, serum, medium, and culture technique, the dose must be determined each time a stable selection is performed. Even the stable cell lines we offer may be more or less sensitive to the dose we recommend if the medium or serum is significantly different.
- Expression of gene product (even low level) may not be compatible with growth of the cell line: Use an inducible expression system.
- Negative clones may result from preferential linearization at a vector site critical for expression of the gene of interest: Linearize the vector at a site that is not critical for expression, such as within the bacterial resistance marker.

I used a mammalian expression vector but do not get any expression of my protein. Can you help me troubleshoot?

Here are possible causes and solutions:

- Try the control expression that is included in the kit
Possible detection problem:

- Detection of expressed protein may not be possible in a transient transfection, since the transfection efficiency may be too low for detection by methods that assess the entire transfected population. We recommend optimizing the transfection efficiency, doing stable selection, or using methods that permit examination of individual cells. You can also increase the level of expression by changing the promoter or cell type.
- Expression within the cell may be too low for the chosen detection method. We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot. Protein might be degraded or truncated: Check on a Northern. Possible time-course issue: Since the expression of a protein over time will depend upon the nature of the protein, we always recommend doing a time course for expression. A pilot time-course assay will help to determine the optimal window for expression. Possible cloning issues: Verify clones by restriction digestion and/or sequencing.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I am using a mammalian expression vector that has the neomycin resistance gene. Can I use neomycin for stable selection in mammalian cells?

No; neomycin is toxic to mammalian cells. We recommend using Geneticin (a.k.a. G418 Sulfate), as it is a less toxic and very effective alternative for selection in mammalian cells.

Is it okay if my construct has an ATG that is upstream of the ATG in my gene of interest? Will it interfere with translation of my gene?

Translation initiation will occur at the first ATG encountered by the ribosome, although in the absence of a Kozak sequence, initiation will be relatively weak. Any insert downstream would express a fusion protein if it is in frame with this initial ATG, but levels of expressed protein are predicted to be low if there is a non-Kozak consensus sequence. If the vector contains a non-Kozak consensus ATG, we recommend that you clone your gene upstream of that ATG and include a Kozak sequence for optimal expression.